Aurora Spine saw its highest first-quarter revenue in 2022 with $3.55 million. That was followed by second-quarter revenue of $4.1 million, the company’s highest quarterly sales in its history, according to an Aug. 29 news release.
CEO Trent Northcutt said results stemmed from Aurora Spine’s 2021 sales and marketing strategy, along with growing surgeon adoption of products.
In the second half of the year, Aurora Spine has plans to launch a titanium version of its sacroiliac joint product, the SiLO-TFX, and exceed its goal of meeting with 400 physicians for training sessions, according to the release.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.